# Phase 4a — Myocardial Dysfunction Completion — 2026-08-10

## Result
The historical myocardial under-response was re-investigated rather than assumed to remain unfixed. Changelog v0.4.0 had already added ventricular source resistance plus nonlinear passive stiffness after the original v0.3.0 under-response disclosure. Current severe LV/RV failure profiles are directionally strong and reversible, so no additional myocardial equation rewrite was justified.

The actual remaining gap was runtime integration. LV/RV contractility modifiers were previously fresh-model engineering inputs only. Phase 4a promotes them into the unified native cardiopulmonary solve through `MyocardialFunctionPort`, includes them in synchronous and asynchronous native-solve cache signatures, and registers `patient.set_myocardial_function` as an authoritative scenario mechanism.

## Clinical/behavior boundary
CBC11 protects direction, graded severity, same-patient reversibility, and the existing severe ipsilateral filling-pressure/chamber-volume phenotype. Exact scale-to-clinical-severity mapping remains provisional. In particular, `0.70`, `0.30`, and `0.15` are regression stimuli rather than named clinical severity grades.

## No GUI scope creep
No myocardial learner control, inotrope control, or new scenario family was added. Phase 4a is a physiology/runtime mechanism milestone.
